RA CAPITAL MANAGEMENT, L.P. Q2 2018 Filing
Filed August 14, 2018
Portfolio Value
$1.5T
Holdings
27
Report Date
Q2 2018
Filing Type
13F-HR
All Holdings (27 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | WVEWAVE LIFE SCIENCES LTD | 7,512,049 | $287.3B | 18.66% | |
| 2 | ASNDASCENDIS PHARMA A S | 4,240,536 | $282.1B | 18.31% | |
| 3 | SLDBSOLID BIOSCIENCES INC | 2,689,444 | $95.8B | 6.22% | |
| 4 | —ENDOCYTE INC | 5,649,884 | $78.0B | 5.06% | |
| 5 | —MOMENTA PHARMACEUTICALS INC | 3,702,533 | $75.7B | 4.92% | |
| 6 | —IMMUNOMEDICS INC | 3,119,778 | $73.8B | 4.79% | |
| 7 | —MYOVANT SCIENCES LTD | 2,830,455 | $64.7B | 4.20% | |
| 8 | IFRXINFLARX NV | 1,967,148 | $63.4B | 4.12% | |
| 9 | TGTXTG THERAPEUTICS INC | 4,278,796 | $56.3B | 3.65% | |
| 10 | SG7SAGE THERAPEUTICS INC | 350,933 | $54.9B | 3.57% | |
| 11 | —ZOGENIX INC | 1,145,268 | $50.6B | 3.29% | |
| 12 | RYTMRHYTHM PHARMACEUTICALS INC | 1,541,743 | $48.2B | 3.13% | |
| 13 | —DICERNA PHARMACEUTICALS INC | 3,933,489 | $48.2B | 3.13% | |
| 14 | —EIDOS THERAPEUTICS INC | 2,162,671 | $44.0B | 2.86% | |
| 15 | BCRXBIOCRYST PHARMACEUTICALS | 6,984,692 | $40.0B | 2.60% | |
| 16 | —RA PHARMACEUTICALS INC | 3,851,808 | $38.3B | 2.49% | |
| 17 | KALAKALA PHARMACEUTICALS INC | 2,113,236 | $29.0B | 1.88% | |
| 18 | APLSAPELLIS PHARMACEUTICALS INC | 900,000 | $19.8B | 1.29% | |
| 19 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 1,525,000 | $16.3B | 1.06% | |
| 20 | SCPHSCPHARMACEUTICALS INC | 2,857,143 | $16.2B | 1.05% | |
| 21 | IOVAIOVANCE BIOTHERAPEUTICS INC | 1,121,153 | $14.4B | 0.93% | |
| 22 | KALVKALVISTA PHARMACEUTICALS INC | 1,441,070 | $11.7B | 0.76% | |
| 23 | —AVEO PHARMACEUTICALS INC | 5,062,759 | $11.4B | 0.74% | |
| 24 | SPROSPERO THERAPEUTICS INC | 741,647 | $10.9B | 0.71% | |
| 25 | GLYCEURGLYCOMIMETICS INC | 253,547 | $4.1B | 0.27% | |
| 26 | —PROTEON THERAPEUTICS INC | 1,337,462 | $3.3B | 0.21% | |
| 27 | GTHXEURG1 THERAPEUTICS INC | 40,000 | $1.7B | 0.11% |